Can B Corp (NASC) stock
NASCOTCWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
Financials through Q3 FY2024, quarter ended Sep 30, 2024Last filing: 10-Q on Nov 19, 2024
$0.01−0.00 (-1.32%)
Close on Oct 19, 2026Market cap $981.54KP/E –Yield –
Can B operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Can B's operating income for the twelve months ending Sep 30, 2024 was -$10.71M. For fiscal 2023 it was -$7.49M. The highest annual figure on record is -$712.79K in fiscal 2017.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | -$7.49M | – |
| FY2022 | Dec 31, 2022 | -$14.17M | – |
| FY2021 | Dec 31, 2021 | -$10.27M | – |
| FY2020 | Dec 31, 2020 | -$7.54M | – |
| FY2019 | Dec 31, 2019 | -$5.89M | – |
| FY2018 | Dec 31, 2018 | -$3.42M | – |
| FY2017 | Dec 31, 2017 | -$712.79K | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2024 | Sep 30, 2024 | -$2.83M | – |
| Q2 FY2024 | Jun 30, 2024 | -$1.57M | – |
| Q1 FY2024 | Mar 31, 2024 | -$5.65M | – |
| Q4 FY2023 | Dec 31, 2023 | -$651.72K | – |
| Q3 FY2023 | Sep 30, 2023 | -$3.58M | – |
| Q2 FY2023 | Jun 30, 2023 | -$1.82M | – |
| Q1 FY2023 | Mar 31, 2023 | -$1.43M | – |
| Q4 FY2022 | Dec 31, 2022 | -$2.59M | – |
| Q3 FY2022 | Sep 30, 2022 | -$6.83M | – |
| Q2 FY2022 | Jun 30, 2022 | -$1.56M | – |
| Q1 FY2022 | Mar 31, 2022 | -$3.19M | – |
| Q4 FY2021 | Dec 31, 2021 | -$3.36M | – |
| Q3 FY2021 | Sep 30, 2021 | -$2.52M | – |
| Q2 FY2021 | Jun 30, 2021 | -$2.59M | – |
| Q1 FY2021 | Mar 31, 2021 | -$1.79M | – |
| Q4 FY2020 | Dec 31, 2020 | -$4.53M | – |
| Q3 FY2020 | Sep 30, 2020 | -$772.64K | – |
| Q2 FY2020 | Jun 30, 2020 | -$1.12M | – |
| Q1 FY2020 | Mar 31, 2020 | -$1.11M | – |
| Q4 FY2019 | Dec 31, 2019 | -$2.35M | – |
| Q3 FY2019 | Sep 30, 2019 | -$935.26K | – |
| Q2 FY2019 | Jun 30, 2019 | -$1.44M | – |
| Q1 FY2019 | Mar 31, 2019 | -$1.17M | – |
| Q4 FY2018 | Dec 31, 2018 | -$1.65M | – |
| Q3 FY2018 | Sep 30, 2018 | -$666.91K | – |
| Q2 FY2018 | Jun 30, 2018 | -$468.44K | – |
| Q1 FY2018 | Mar 31, 2018 | -$634.69K | – |
See a number that looks wrong?